Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$326,133
+$3,984 QoQ
Shares Held
2,081
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,083
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Enterprise Financial Services Corp holds $12,653,618 across 10 Drug Manufacturers - General names. NVS ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,105 | $3,297,741 | |
| 2 | LLY |
ELI LILLY & Co
|
2,069 | $2,481,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 4 | JNJ |
Johnson & Johnson
|
8,275 | $2,101,601 | |
| 5 | PFE |
Pfizer Inc
|
24,377 | $586,998 | |
| 6 | AMGN |
Amgen Inc
|
1,281 | $463,875 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,683 | $442,694 | |
| 8 | NVS |
Novartis AG
This page
|
2,081 | $326,133 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,133 | 2,081 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $322,149 | 2,109 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $320,271 | 2,323 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $303,543 | 2,367 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $293,932 | 2,429 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $247,707 | 2,222 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $293,486 | 3,016 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $328,496 | 2,856 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $310,437 | 2,916 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $315,726 | 3,264 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $334,816 | 3,316 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $319,228 | 3,134 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $312,720 | 3,099 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $292,008 | 3,174 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $273,883 | 3,019 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $232,286 | 3,056 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $263,226 | 3,114 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $259,125 | 2,953 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $238,355 | 2,725 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $264,802 | 3,238 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $247,897 | 2,717 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $269,175 | 3,149 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $288,199 | 3,052 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $265,574 | 3,054 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $291,104 | 3,333 | Shares | Other | 2020-08-04 | |
| 2020-03-31 | $221,295 | 2,684 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||